About
This medication is a dual-action lipid-modifying therapy combining Rosuvastatin, an HMG-CoA reductase inhibitor, with Fenofibrate, a fibric acid derivative. Rosuvastatin primarily targets cholesterol synthesis in the liver, leading to a substantial reduction in low-density lipoprotein (LDL-C) and total cholesterol, while also providing a modest increase in high-density lipoprotein (HDL-C). Fenofibrate, on the other hand, primarily acts by activating peroxisome proliferator-activated receptor alpha (PPARα), which significantly reduces elevated triglyceride levels and further increases HDL-C. This complementary mechanism of action makes the combination particularly effective for patients with mixed dyslipidemia, especially those presenting with high triglycerides, low HDL-C, and elevated LDL-C, who require comprehensive lipid profile improvement. It offers a robust strategy to manage complex lipid disorders and reduce associated cardiovascular risks.
Uses
- Treatment of mixed dyslipidemia
- Severe hypertriglyceridemia
- Primary hypercholesterolemia with high triglycerides
- Reduction of cardiovascular risk in specific dyslipidemic profiles
Directions For Use
Take one tablet orally once daily, preferably with a meal, or as directed by your physician.
Benefits
- Significantly lowers LDL ("bad") cholesterol
- Reduces very high triglyceride levels
- Increases HDL ("good") cholesterol
- Decreases total cholesterol
- Provides comprehensive lipid profile improvement
- Reduces the risk of pancreatitis due to high triglycerides
Side Effects
- Muscle pain (myalgia)
- Headache
- Nausea
- Abdominal pain
- Diarrhea
- Constipation
- Fatigue
- Increased liver enzymes
- Gallstones (cholelithiasis)
- Pancreatitis
- Rash
- Dizziness
Safety Measures
- Alcohol - Excessive alcohol intake can increase the risk of liver damage and muscle problems (rhabdomyolysis) when combined with this medication.
- Pregnancy - Contraindicated in pregnancy due to potential fetal harm; avoid use.
- Breastfeeding - Not recommended during breastfeeding as both components may pass into breast milk.
- Liver - Contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. Use with extreme caution in liver impairment.
- Kidney - Contraindicated in severe renal impairment. Dose adjustment is necessary in moderate renal impairment.
- Lung - Generally safe for use in patients with lung conditions; no specific contraindications.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!